The "Start-Stop" Reality: New Data Reveals Complex Patterns in GLP-1 Adherence for Type 2 Diabetes
Comments Off on The "Start-Stop" Reality: New Data Reveals Complex Patterns in GLP-1 Adherence for Type 2 Diabetes
June 17, 2026
CHICAGO — The landscape of type 2 diabetes management has been irrevocably altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists. Drugs like liraglutide, semaglutide, and tirzepatide have become cornerstones of modern metabolic…
A New Frontier in Diabetes Care: Breakthrough Phase 2b Results for Oral GLP-1 Candidate Elecoglipron
Comments Off on A New Frontier in Diabetes Care: Breakthrough Phase 2b Results for Oral GLP-1 Candidate Elecoglipron
June 16, 2026
The landscape of type 2 diabetes management is poised for a significant transformation as researchers unveil promising data regarding the next generation of oral GLP-1 receptor agonists. At the American Diabetes Association’s (ADA) recent Scientific…